Unknown

Dataset Information

Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis.


ABSTRACT: CFTR gene mutations that result in the introduction of premature termination codons (PTCs) are common in cystic fibrosis (CF). This mutation type causes a severe form of the disease, likely because of low CFTR messenger RNA (mRNA) expression as a result of nonsense-mediated mRNA decay, as well as the production of a nonfunctional, truncated CFTR protein. Current therapeutics for CF, which target residual protein function, are less effective in patients with these types of mutations due in part to low CFTR protein levels. Splice-switching antisense oligonucleotides (ASOs), designed to induce skipping of exons in order to restore the mRNA open reading frame, have shown therapeutic promise preclinically and clinically for a number of diseases. We hypothesized that ASO-mediated s

SUBMITTER: Michaels WE 

PROVIDER: S-EPMC8784102 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature